Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: R Hamilton who wrote (913)	5/12/1998 4:54:00 PM
From: RIP	Respond to of 1476

ANTX holders, 10Q is out. No surprises. They had a ($0.01)/share. ($260,000) for the quarter. Of note, admin expenses are down 30+%, that's nice and the last quarter we will get a $500,000 payment from PM in Dec '98 which will make up a nice portion. Also, this year SBH payment(which starts in March of this year until Feb '99) goes from 2.8 mil annually to $3.2 mil annually. Sooo...about $400,000 more will be recognized for the remainder of this year. On the negative side, it will cost a little more for R&D with the new scientists (but R&D is a good expense IMO). If the warrants exercise that will be a wash because the $3 mil will turn into stock dilution, so I don't consider that good. I guess that this year will be a total loss of approx. $500,000 ($0.01-$0.02) for the year. That is a pretty sound burn rate as Dr. Vic is concerned with keeping costs down. Just wish the stock would reflect this more. In for the long haul, so I'll just wait. Regards, Rip